Potency of pertussis component in the DTP vaccine – an overview of three decade study in Poland

This publication has 14 references indexed in Scilit:

• Genotypic Variation in the Bordetella pertussis Virulence Factors Pertactin and Pertussis Toxin in Historical and Recent Clinical Isolates in the United Kingdom
  Infection and Immunity, 2001
• Polymorphism inBordetella pertussisPertactin and Pertussis Toxin Virulence Factors in the United States, 1935–1999
  The Journal of Infectious Diseases, 2000
• Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data
  Emerging Infectious Diseases, 2000
• Epidemiological Typing of Bordetella pertussis Isolates: Recommendations for a Standard Methodology
  European Journal of Clinical Microbiology & Infectious Diseases, 2000
• Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children
  Microbiology, 1999
• Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine1Financial support for the present study was provided by the Institut Pasteur Fondation and SmithKline Beecham Biologicals. All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1
  Vaccine, 1999
• Polymorphism in the Bordetella pertussis Virulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution
  Infection and Immunity, 1998
• Impact of anti-vaccine movements on pertussis control: the untold story
  The Lancet, 1998
• Return of epidemic pertussis in the United States
  The Pediatric Infectious Disease Journal, 1994
• Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?
  The Journal of Infectious Diseases, 1993